Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 267

1.

Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.

Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ.

N Engl J Med. 1991 Nov 7;325(19):1325-9.

2.

Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.

Esteban JI, González A, Hernández JM, Viladomiu L, Sánchez C, López-Talavera JC, Lucea D, Martin-Vega C, Vidal X, Esteban R, et al.

N Engl J Med. 1990 Oct 18;323(16):1107-12.

3.
4.

Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.

Mathiesen UL, Ekermo B, Foberg U, Franzén L, Frydén A, Norlin R, Pettersson LG, Sterling H, Widell A, Bodemar G.

Scand J Gastroenterol. 1992 Jun;27(6):443-8.

PMID:
1321487
5.

Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low-risk population.

MacDonald KL, Mills WA, Wood RC, Hanson M, Kline W, Bowman RJ, Polesky HF, Williams AE, Osterholm MT.

Transfusion. 1994 Mar;34(3):202-8.

PMID:
8146891
6.

Post-transfusion hepatitis revisited.

Ismay SL, Thomas S, Fellows A, Keller A, Kenrick KG, Archer GT, Wylie BR, Cossart YE.

Med J Aust. 1995 Jul 17;163(2):74-7.

PMID:
7542359
7.

Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.

Edelenyi-Pinto M, Carvalho AP, Nogueira C, Ferreira Júnior O, Schechter M.

Mem Inst Oswaldo Cruz. 1993 Apr-Jun;88(2):305-7.

8.

Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial.

González A, Esteban JI, Madoz P, Viladomiu L, Genesca J, Muñiz E, Enríquez J, Torras X, Hernández JM, Quer J, et al.

Hepatology. 1995 Aug;22(2):439-45.

PMID:
7635410
9.

Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.

Barrera JM, Bruguera M, Ercilla MG, Sánchez-Tapias JM, Gil MP, Costa J, Gelabert A, Rodés J, Castillo R.

Ann Intern Med. 1991 Oct 15;115(8):596-600.

PMID:
1909848
10.

The declining risk of post-transfusion hepatitis C virus infection.

Donahue JG, Muñoz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, Reitz BA, Nelson KE.

N Engl J Med. 1992 Aug 6;327(6):369-73.

11.

Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission.

Watanabe M, Ohkoshi S, Tawaraya H, Miyajima T, Shimotohno K, Kamimura T, Asakura H.

Transfusion. 1994 Feb;34(2):125-9.

PMID:
7508643
13.

Hepatitis C virus infection from blood and blood products.

van der Poel CL.

FEMS Microbiol Rev. 1994 Jul;14(3):241-6. Review.

PMID:
7522022
14.

Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays.

Lelie PN, Cuypers HT, Reesink HW, van der Poel CL, Winkel I, Bakker E, van Exel-Oehlers PJ, Vallari D, Allain JP, Mimms L.

J Med Virol. 1992 Jul;37(3):203-9.

PMID:
1331309
15.

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G.

N Engl J Med. 1989 Nov 30;321(22):1494-500.

PMID:
2509915
16.

Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay.

Lai ME, De Virgilis S, Argiolu F, Farci P, Mazzoleni AP, Lisci V, Rapicetta M, Clemente MG, Nurchis P, Arnone M, et al.

J Pediatr Gastroenterol Nutr. 1993 May;16(4):458-64.

PMID:
7686220
17.

Incidence of post-transfusion hepatitis before and after screening for hepatitis C virus antibody.

Wang YJ, Lee SD, Hwang SJ, Chan CY, Chow MP, Lai ST, Lo KJ.

Vox Sang. 1994;67(2):187-90.

PMID:
7528456
18.

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.

Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, DiBisceglie A, Hoofnagle J, Shih JW, et al.

N Engl J Med. 1996 Jun 27;334(26):1691-6.

19.

Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay.

Huang YY, Yang SS, Wu CH, Shih WS, Huang CS, Chen PH, Lin YM, Shen CT, Chen DS.

Transfusion. 1994 Aug;34(8):661-5.

PMID:
7521077
20.

Follow-up study of anti-hepatitis C virus antibodies in blood donors implicated in post-transfusion non-A, non-B hepatitis.

Mazda T, Nakata K, Bannai M, Miyamura T, Chiba J, Ohba H, Kaminuma Y, Katayama T.

Transfus Med. 1993 Jun;3(2):149-51.

PMID:
7690640

Supplemental Content

Support Center